Cargando…

RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity

The pathophysiology of retinopathy of prematurity (ROP) is postulated to first involve delayed intraretinal vascularization, followed by intravitreal neovascularization (IVNV). Although intravitreal agents that reduce the bioactivity of vascular endothelial growth factor (VEGF) are used to treat IVN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramshekar, Aniket, Bretz, Colin A., Hartnett, M. Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266443/ https://www.ncbi.nlm.nih.gov/pubmed/35806359 http://dx.doi.org/10.3390/ijms23137354

Ejemplares similares

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental Murine Model
por: Fung, Camille, et al.
Publicado: (2023)

Regulation of Rac1 Activation in Choroidal Endothelial Cells: Insights into Mechanisms in Age-Related Macular Degeneration
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Signaling Through the Erythropoietin Receptor Affects Angiogenesis in Retinovascular Disease
por: Bretz, Colin A., et al.
Publicado: (2020)

Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization
por: Ramshekar, Aniket, et al.
Publicado: (2022)

RNA-Seq Reveals a Role for NFAT-Signaling in Human Retinal Microvascular Endothelial Cells Treated with TNFα
por: Savage, Sara R., et al.
Publicado: (2015)

Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018)

Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018)

Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity
por: Hartnett, M. Elizabeth, et al.
Publicado: (2023)

Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity
por: Han, Xiaokun, et al.
Publicado: (2019)

LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy
por: Gong, Qiaoyun, et al.
Publicado: (2020)

Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Current Concepts of Oxygen Management in Retinopathy of Prematurity
por: Owen, Leah A., et al.
Publicado: (2014)

7-Ketocholesterol Promotes Retinal Pigment Epithelium Senescence and Fibrosis of Choroidal Neovascularization via IQGAP1 Phosphorylation-Dependent Signaling
por: Wang, Haibo, et al.
Publicado: (2023)

Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity
por: Geisen, P., et al.
Publicado: (2008)

The Effects of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Erythropoietin, and Their Interactions in Angiogenesis: Implications in Retinopathy of Prematurity
por: Cung, Thaonhi, et al.
Publicado: (2022)

KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells
por: Wang, Yinan, et al.
Publicado: (2015)

Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016)

Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity
por: Hartnett, M Elizabeth, et al.
Publicado: (2016)

Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2–induced intravitreal neovascularization in a rat model of retinopathy of prematurity
por: Wang, Haibo, et al.
Publicado: (2014)

The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies
por: Medina, Reinhold J., et al.
Publicado: (2008)

Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture
por: Hartnett, M. Elizabeth
Publicado: (2019)

Retinopathy of Prematurity in Infants with Late Retinal Examination
por: Mousavi, S. Zeinab, et al.
Publicado: (2009)

Retinal, visual, and refractive development in retinopathy of prematurity
por: Moskowitz, Anne, et al.
Publicado: (2016)

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014)

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma?
por: Azad, Rajvardhan
Publicado: (2011)

Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity
por: Hartmann, John S., et al.
Publicado: (2011)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
por: Pertl, Laura, et al.
Publicado: (2015)

Porphyromonas gingivalis outer membrane vesicles exacerbate retinal microvascular endothelial cell dysfunction in diabetic retinopathy
por: Huang, Shengyuan, et al.
Publicado: (2023)

Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016)

Retracted: Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Diabetes Research, Journal of
Publicado: (2020)

The Relationship between the Aqueous VEGF Level and the Severity of Type 1 Retinopathy of Prematurity
por: Liang, Tianwei, et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
por: Arrigo, Alessandro, et al.
Publicado: (2022)

Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study
por: Ghassemi, Fariba, et al.
Publicado: (2022)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
por: Li, Zijing, et al.
Publicado: (2018)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
por: Kondo, Chiori, et al.
Publicado: (2022)

Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity
por: Berkowitz, Bruce A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c0kv1hqckp5flji0bgp8egk17s